packageCarfilzomib

carfilzomib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Carfilzomib is a proteasome inhibitor used to treat multiple myeloma. It is an approved medicine, authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q15366934 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:carfilzomib
ATC codes:L01XG02, L01XX45
DrugBank:DB08889
PubChem CID:11556711
ChEBI:65347
Wikidata:Q15366934
formula:C40H57N5O7
molar mass:719.924 g/mol (PubChem CID 11556711)
logP:4.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown